Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study

Dimitriou, F., Namikawa, K., Reijers, I. L. M., Buchbinder, E. I., Soon, J. A., Zaremba, A., Teterycz, P., Mooradian, M. J., Armstrong, E., Nakamura, Y., Vitale, M. G., Tran, L. E., Bai, X., Allayous, C., Provent-Roy, S., Indini, A., Bhave, P., Farid, M., Kähler, K. C., … Long, G. V. (2022). Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study. Annals of Oncology, 33(9), 968–980. https://doi.org/10.1016/j.annonc.2022.06.004
Authors:
F Dimitriou
K Namikawa
I L M Reijers
E I Buchbinder
J A Soon
A Zaremba
P Teterycz
M J Mooradian
E Armstrong
Y Nakamura
M G Vitale
L E Tran
X Bai
C Allayous
S Provent-Roy
A Indini
P Bhave
M Farid
K C Kähler
I Mehmi
V Atkinson
O Klein
C J Stonesifer
F Zaman
A Haydon
R D Carvajal
O Hamid
R Dummer
A Hauschild
M S Carlino
M Mandala
C Robert
C Lebbe
J Guo
D B Johnson
P A Ascierto
A N Shoushtari
R J Sullivan
B Cybulska-Stopa
P Rutkowski
L Zimmer
S Sandhu
C U Blank
S N Lo
A M Menzies
G V Long
Affiliated Authors:
C J Stonesifer
R D Carvajal
Subjects:
Cancer Immunotherapy (OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Immunobiology of Dendritic Cells (OpenAlex Topic)
Lung Neoplasms (MeSH)
Melanoma (MeSH)
Author Keywords:
anti-pd-1
ipilimumab
immunotherapy
mucosal melanoma
ethnicity/race
elink
Publication Type:
Article
Unique ID:
10.1016/j.annonc.2022.06.004
PMID:
35716907
DOI:
10.1016/j.annonc.2022.06.004
Journal:
Annals of Oncology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record
View OpenAlex Record

Record Created: